<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02547207</url>
  </required_header>
  <id_info>
    <org_study_id>CR-13-004-EU-HF</org_study_id>
    <nct_id>NCT02547207</nct_id>
  </id_info>
  <brief_title>MultiPoint Pacing Mapping Study</brief_title>
  <official_title>MultiPoint Pacing Mapping Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to characterize left ventricular acute hemodynamic and
      electrical responses during cardiac resynchronization therapy (CRT) with different Multipoint
      Pacing (MPP) settings, and assess the relationship between electrical activation patterns and
      hemodynamic measurements during these pacing settings.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular (LV) dP/dt Max (maximum change in pressure over time) in mmHg/s during different pacing settings</measure>
    <time_frame>up to 30 days post-implant</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Heart failure patients meeting specific eligibility criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be scheduled to undergo or have received within the past 30 days an implant of a SJM
             (St. Jude Medical) MPP CRT-D system with approved standard indication by ESC (European
             Society of Cardiology) / EHRA (European Heart Rhythm Association) Guidelines

          -  Have the ability to provide informed consent for study participation and be willing
             and able to comply with the Clinical Investigation Plan (CIP) described evaluations
             and follow-up schedule

          -  Be in sinus rhythm

        Exclusion Criteria:

          -  Complete AV (atrioventricular) block

          -  Permanent atrial fibrillation

          -  Have a recent myocardial infarction within 40 days prior to enrollment

          -  Have undergone cardiac surgery or coronary revascularization procedure within 3 months
             prior to enrollment or be scheduled for such procedures in the following 7 months

          -  Have had a recent CVA (cerebrovascular accident) or TIA (transient ischemic attack)
             within 3 months prior to enrollment

          -  Have had intravenous inotropic support in the last 30 days

          -  Be less than 18 years of age

          -  Be pregnant or plan to become pregnant over the next 7 months

          -  Have significant peripheral vascular disease

          -  Have LV thrombus

          -  Significant aortic valve disease or replacement

          -  Mitral valvular disease

          -  Contraindicated for Gadolinium contrast agent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe Leclercq, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Rennes, Rennes, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fujian Qu, DSc</last_name>
    <phone>(408) 738-4883</phone>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christophe Leclercq, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kerckhoff-Klinik GmbH</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>D-61231</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Johannes Sperzel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Dresden Universit√§tsklinik</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Christopher Piorkowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Thomas Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Christopher A. Rinaldi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2015</study_first_submitted>
  <study_first_submitted_qc>September 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2015</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

